Microdosing has gained popularity as the primary approach to taking psychedelics. It refers to taking tiny, minute amounts of the drug in doses so low they don’t actually induce hallucinations or cause a major altered state of consciousness. The doses are often so low that the effects aren’t obvious (but that would be the whole point) - and individuals can still stay productive.

GOP Senator Thom Tillis recently voiced his opposition to Trump's Schedule III rescheduling order, dusting off that old faithful propaganda chestnut: marijuana is a gateway drug. You know, the theory that smoking a joint inevitably leads to shooting heroin in a back alley while your life crumbles around you.

When they were asked if they think recreational cannabis should be legalized around the country, 54% agreed, while 27% were opponents of legalization. Meanwhile, 19% remained unsure. The respondents’ political affiliation had an impact on their responses. Almost 7 out of 10 Democrats supported legalization, and most Independents were also supportive.

Researchers analyzed HIV patients—one of the most medically vulnerable populations you can study—and found that cannabis use was not associated with heart abnormalities. Let me repeat that for the people in the back: not associated with heart abnormalities.

Cannabis is one of the best natural therapies out there for ADHD, but it should be used with careful thought and caution. Keep in mind that the very same product that can help improve focus for someone with ADHD can cause another to get derailed if the timing or dosage is off.

Given there are serious limitations to pharmaceutical cannabinoid medications, it’s clear that the problem lies in the insurance system that has yet to evolve alongside patients' needs and medical science. There is a clear disconnect when insurance companies can cover synthetic cannabinoid drugs but can’t acknowledge the medicinal value of whole cannabis compounds. Then again, the issue circles back to the federal government.

Take cannabis, for example—my favorite barometer for societal sanity. We went from "this will literally destroy your brain and turn you into a violent criminal" to "okay maybe it's medicine" to "actually it's legal in half the states" to "wait no we're banning hemp THC and maybe repealing legalization entirely" to "Schedule III but only for Big Pharma" all within a couple of decades. And we're supposed to pretend this makes sense?

Furthermore, Schedule III could mean that independent researchers—not just pharma shills—might finally get a seat at the table. Universities won't have to fear losing their funding just for touching the plant. We might see a new wave of "less biased" research that explores the nuances of the entourage effect or minor cannabinoids like THCV or CBG, rather than just focusing on how much "reefer madness" can be induced in a lab rat.

Well, folks, we made it through another year in the wildest timeline. 2025 was a rollercoaster ride through cannabis policy chaos, and I've got the whiplash to prove it. As I sit here reflecting on the year that was, I'm reminded that trying to make sense of cannabis policy in America is like trying to nail Jell-O to a wall while riding a unicycle backwards. It's messy, it's unpredictable, and you're probably going to fall on your ass.

Have you scromited yet? No? Well, buckle up, because that's the latest buzzword the propaganda machine wants you to associate with cannabis. And if you haven't heard of it yet, don't worry—you will. They're making sure of that.